Publicaciones › Cribado, telemedicina (OPHDIAT) y epidemiología de la retinopatía diabética
Prevalence, severity stages, and risk factors of diabetic retinopathy in 1464 adult patients with type 1 diabetes
Prevalencia, estadios de gravedad y factores de riesgo de la retinopatía diabética en 1464 pacientes adultos con diabetes tipo 1
| Año | 2021 |
|---|---|
| Fuente | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie |
| Tipo | article · Journal Article |
| Autores (10) | Abir Zureik, Jean-Baptiste Julla, Ali Erginay, Tiphaine Vidal-Trecan, Vanessa Juddoo, Jean-François Gautier, Pascale Massin, Ramin Tadayoni, Jean-Pierre Riveline, Aude Couturier |
| Posición de Erginay | 3 de 10 |
| Citas | 21 (OpenAlex) |
| Enlaces | DOI 10.1007/s00417-021-05298-7 · PubMed 34264396 · OpenAlex |
| Líneas | Cribado, telemedicina (OPHDIAT) y epidemiología de la retinopatía diabética Enfermedades vasculares, genéticas e inflamatorias de la retina Retinopatía diabética: clínica, función y progresión |
En pocas palabras
Se estudió la prevalencia de la retinopatía diabética en pacientes adultos con diabetes tipo 1. El estudio encontró que el 50.1% de los pacientes tenían retinopatía diabética y que la duración de la diabetes y los niveles de hemoglobina A1c eran factores de riesgo importantes. Los resultados sugieren que el control de la diabetes es crucial para prevenir la retinopatía diabética.
Resumen divulgativo generado automáticamente a partir del resumen original; puede contener imprecisiones.
Resumen original
To determine the prevalence of diabetic retinopathy (DR) and its risk factors in adult type 1 diabetes (T1D) patients METHODS: In this cross-sectional study, all T1D patients followed in the University Center for Diabetes and its Complications of Lariboisière Hospital (Paris, France) between January 2017 and February 2019 were included. Ophthalmologic and systemic data were collected from electronic records. The association between DR (and each grade) and associated factors were estimated by univariate and multivariate analyses using logistic regression models. A total of 1464 patients (46.2% of women, mean age: 42.2 ± 15.8 years) were included. The mean hemoglobin A1c (HbA1c) was 7.8 ± 1.7% and the mean diabetes duration was 20.5 ± 13.5 years. DR prevalence was 50.1% (47.4-52.6) and the prevalence of mild, moderate, and severe non-proliferative DR and proliferative DR was 19.1%, 9.4%, 3.9%, and 17.6%, respectively. DR was significantly associated with male gender, an older age, former and current smoking status, a higher BMI, the presence of nephropathy and neuropathy, higher HBA1c, and longer diabetes duration. Patients with HbA1c > 10% had an adjusted odds ratio (OR) of 3.25 (1.77-6.01) of having DR compared to patients with HbA1c < 6.5%. Patients with a diabetes duration > 30 years had an adjusted OR of 24.87 (14.82-42.67) higher of having DR compared to patients with a diabetes duration < 10 years. In this study, 50.1% of adult T1D patients had DR and 17.6% had proliferative DR. Diabetes duration and HbA1c were major risk factors.